PhoenixBio (6190) · FactRestated
Transfer to the Tokyo Stock Exchange Growth Market
First written in FY2022. 2 of 3 entries say "Restated". Latest entry: FY2023.
3entries
2years
0from disclosures
How it moved
Same theme, other companies
Transition to and Continued Listing on the Tokyo Stock Exchange Growth MarketA theme 60 companies write about · 0 as a headwind · 9 as a tailwind
The whole theme swung hardest in 2026: 5 of 13 companies on the "Worse" side.
17 other companies' latest entry also says "Restated".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 60 companies compared. The sentences above are computed from all 60.Full recordFilings, disclosures and news, newest first
- FY2023RestatedAnnual report
「The highest and lowest share prices are those on the Tokyo Stock Exchange Growth Market from 4 April 2022 onward, and those on the Tokyo Stock Exchange Mothers market before that date.」
The full-year disclosure reconfirmed the company’s move to the Tokyo Stock Exchange Growth Market. - FY2023-Q1RestatedAnnual report
「Tokyo Stock Exchange (Growth Market)」
Reconfirms the listing on the Tokyo Stock Exchange Growth Market. - FY2022First statedAnnual report
「April 2022 Moved from the Mothers market to the Growth market following the Tokyo Stock Exchange’s market segment review」
The company moved from the Mothers market to the Growth market in connection with the market segment review in April 2022.